A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare.
about
How do hospital professionals involved in a randomised controlled trial perceive the value of genotyping vs. PCR-ribotyping for control of hospital acquired C. difficile infections?From accuracy to patient outcome and cost-effectiveness evaluations of diagnostic tests and biomarkers: an exemplary modelling study.Research waste in diagnostic trials: a methods review evaluating the reporting of test-treatment interventionsTest-treatment RCTs are susceptible to bias: a review of the methodological quality of randomized trials that evaluate diagnostic tests.Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol.Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.The "linked evidence approach" to assess medical tests: a critical analysis.A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models.Added value of cost-utility analysis in simple diagnostic studies of accuracy: (18)F-fluoromethylcholine PET/CT in prostate cancer staging.Analyzing paired diagnostic studies by estimating the expected benefit.Interim analyses in diagnostic versus treatment studies: differences and similaritiesImpact of Modified Transesophageal Echocardiography on Mortality and Stroke after Cardiac Surgery: A Large Cohort Study.Comparing diagnostic tests: trials in people with discordant test results.Demonstrating the benefits of clinical nuclear imaging: is it time to add economic analysis?Methodologic approaches to evaluating new highly sensitive diagnostic tests: avoiding overdiagnosis.Nutzenbewertung diagnostischer Maßnahmen – quo vadimus?
P2860
Q30576873-93C5EB6F-D6FB-4031-8AE3-F6F6F491E2A9Q34569710-1D5EF568-5B31-4640-9C49-F09332031BD4Q36288765-00B55606-2910-449F-9B8F-50A7D4F1A0BCQ36290699-9920930E-CCF8-4765-9EF6-EC4512831574Q36302726-72AC806E-250E-40FC-9230-5937916FB2F9Q37731264-7CCA38A6-1E43-4C11-952E-95BB3DB6DD26Q38114616-E026D0CC-4CFB-40EE-A257-69336C1D9041Q39039319-04DAAEB6-2A06-433B-924B-AEADD673E26CQ39607551-42E535D6-B2A6-4EEA-B9CE-F4B8D6AEA3EBQ41158264-BC92B314-666F-4804-B269-F5E4A1B3D076Q42410759-F5741613-5987-4AE8-B948-A40A59915452Q42729193-8A30F3CD-7D00-432E-855E-02546D261B1DQ44102194-8A3F094A-C503-499E-B9E3-67EC2813E978Q53061052-F2E7A7B9-FCA8-4C38-A57E-CE17FFDA7E4AQ55092892-45292E65-3BCE-42E9-B0A3-F95CA675ABEFQ58433755-5AF63477-1F91-4CE7-811C-BFE7C178358A
P2860
A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A capture-recapture analysis d ...... on patient outcomes are rare.
@en
A capture-recapture analysis d ...... on patient outcomes are rare.
@nl
type
label
A capture-recapture analysis d ...... on patient outcomes are rare.
@en
A capture-recapture analysis d ...... on patient outcomes are rare.
@nl
prefLabel
A capture-recapture analysis d ...... on patient outcomes are rare.
@en
A capture-recapture analysis d ...... on patient outcomes are rare.
@nl
P2093
P1476
A capture-recapture analysis d ...... s on patient outcomes are rare
@en
P2093
Anne Eisinga
Chris Hyde
Clare Davenport
P304
P356
10.1016/J.JCLINEPI.2011.07.003
P577
2011-10-17T00:00:00Z